comparemela.com
Home
Live Updates
FDA Approves High-Concentration, Citrate-Free Cyltezo for th
FDA Approves High-Concentration, Citrate-Free Cyltezo for th
FDA Approves High-Concentration, Citrate-Free Cyltezo for the Treatment of Chronic Inflammatory Diseases
This citrate-free and high-dose approval of the biosimilar Humira provides another option to treat patients who are living with various inflammatory diseases.
Related Keywords
United States ,
Americans ,
Steven Taylor ,
Stephen Pagnotta ,
Biosimilar Adalimumab Adbm ,
Boehringer Ingelheim ,
Crohn Colitis Foundation ,
Arthritis Foundation ,
Michael Osso ,
Colitis Foundation ,
Healthy People ,
Test How ,
Body When Given ,